Historical position

Nelson Peltz’s Procter & Gamble (PG) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Trian Fund ManagementVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ4 2016Earliest verified positive filing snapshot
Latest statusHistorical positionBased on the latest supported relationship state
Peak shares37.91MHighest verified quarter-end share count
Quarters reported24Verified quarters with shares above zero
What happened?

Trian Fund Management first reported Procter & Gamble in Q4 2016. The reported position was increased and reduced across later filings. Verified positive position history runs through Q3 2022. The current relationship status cannot be determined reliably from supported data.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q3 2022
Bought 2.4% more+132 shares · 5.59K shares reported after the change
Filing context

Quarter-end price $126.32 · Estimated holding basis $89.70

Q1 2022
Sold 97.7% of the position−231.93K shares · 5.46K shares remained
Filing context

Quarter-end price $163.64 · Estimated holding basis $88.82

Q4 2021
Sold 95.5% of the position−5.03M shares · 237.38K shares remained
Filing context

Quarter-end price $163.58 · Estimated holding basis $88.82

Q3 2021
Sold 9.0% of the position−522.26K shares · 5.27M shares remained
Filing context

Quarter-end price $139.80 · Estimated holding basis $88.82

Q2 2021
Sold 34.8% of the position−3.09M shares · 5.79M shares remained
Filing context

Quarter-end price $134.93 · Estimated holding basis $88.82

Q1 2021
Sold 9.6% of the position−938.85K shares · 8.88M shares remained
Filing context

Quarter-end price $135.43 · Estimated holding basis $88.82

5 unchanged quarters are collapsed by default.

Portfolio importance

How important was Procter & Gamble in Trian Fund Management’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.0%Q3 2022
Last reported rank#8of 8 reported positions
Peak portfolio weight49.2%Q1 2020
Best historical rank#1Q1 2017
At peak importanceQ1 2020
PG
49.2%
Largest holding
49.2%
Cross-investor discovery

Who else owns Procter & Gamble?

Also reported by 4 other tracked investors in their latest verified filings.

Terry SmithFundsmith LLP
PG4.4% of reported portfolio
Ray DalioBridgewater Associates, LP
PG0.1% of reported portfolio
Joel GreenblattGotham Asset Management
PG0.1% of reported portfolio
Explore Procter & Gamble across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$146.392026-09-18

Market context only; not an investor transaction price.

Latest filing quarter-end price$126.32Q3 2022

Derived from validated reported value and shares where supported.

Estimated holding basis$89.70Historical reference — not actual purchase price

Calculated from supported filing history.

Latest verified investor filingQ2 2026 · filed 2026-08-12
Open SEC filing ↗

View Procter & Gamble stock page →

This tracker follows Trian Fund Management, L.P.’s Form 13F disclosures—not Nelson Peltz’s personal brokerage account. Form 13F reports quarter-end U.S.-listed positions and certain options, but it does not reveal exact trade dates, execution prices, short positions or the purpose of an option position.